ATEC
Alphatec Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$8.27
+10.64%Oct 30, 2026, 12:53 UTC
Alphatec Holdings, Inc. cut its full-year outlook as fewer surgeons purchased its add-on bone-graft products used for spinal fusion.
Source:Oct 30, 2026, 12:53 UTC
Alphatec Holdings, Inc. shares fell 32%.
Source:Oct 30, 2026, 00:06 UTC
Alphatec Holdings, Inc. reported quarterly earnings of $0.09 per share, below the Zacks Investment Research, Inc. Consensus Estimate of $0.11 and up from $0.03 per share a year earlier.
Source:Oct 29, 2026, 21:59 UTC
Alphatec Holdings reported third-quarter 2026 revenue of $221.172 million, up 13% year over year, and a GAAP net loss of $5.471 million.
Oct 19, 2026, 20:35 UTC
Alphatec Holdings announced that it will report third-quarter 2026 financial results on October 29, 2026, after market close, and host a live webcast at 1:30 p.m. PT.
Source:Sep 14, 2026, 11:15 UTC
Alphatec (ATEC) shares surged 19.7% in the last trading session on above-average volume.
Source:Sep 11, 2026, 13:15 UTC
Alphatec Holdings CEO Miles bought $1 million worth of the company's own shares.
Source:Aug 4, 2026, 22:04 UTC
Alphatec reported second-quarter 2026 revenue of $214 million, up 15% year-over-year, with growth in surgical procedures and surgeon adoption supporting higher profitability and positive free cash flow.
May 5, 2026, 00:00 UTC
Alphatec Holdings, Inc. entered into new senior secured credit facilities (Term Loan A and Revolving Credit Facility) due 2031, using the proceeds to repay all outstanding obligations under its prior credit agreements and pay related fees.